Sleep apnoea in patients with heart failure: Part II: Therapy

Archives of Cardiovascular Diseases

Volumn 102, Issue 10, 2009, Pages 711-720

  Bordier, Philippe ^a  

^a HAUT LÉVÊQUE HOSPITAL   (France)

Author keywords

Heart failure; Sleep apnoea

Indexed keywords

ACETAZOLAMIDE; CARVEDILOL; PLACEBO; THEOPHYLLINE;

CARDIAC RESYNCHRONIZATION THERAPY; CHEYNE STOKES BREATHING; CLINICAL TRIAL; HEART FAILURE; HUMAN; MORBIDITY; MORTALITY; POSITIVE END EXPIRATORY PRESSURE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SLEEP APNEA SYNDROME; SURVIVAL RATE;

EID: 72949123019     PISSN: 18752136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acvd.2009.06.005     Document Type: Review

References (53)

1. Morgenthaler TI, Aurora RN, Brown T, et al. Practice parameters for the use of autotitrating continuous positive airway pressure devices for titrating pressures and treating adult patients with obstructive sleep apnea syndrome: an update for 2007. An American Academy of Sleep Medicine report. Sleep 2008;31:141-147
2. Marin JM, Carrizo SJ, Vicente E, et al. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005;365:1046-1053 (Pubitemid 40386782)
3. Oldenburg O, Lamp B, Faber L, et al. Sleep-disordered breathing in patients with symptomatic heart failure: a contemporary study of prevalence in and characteristics of 700 patients. Eur J Heart Fail 2007;9:251-257 (Pubitemid 46335886)
4. Sin DD, Fitzgerald F, Parker JD, et al. Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med 1999;160:1101-1106 (Pubitemid 29487445)
5. Kaneko Y, Floras JS, Usui K, et al. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 2003;348:1233-1241 (Pubitemid 36359299)
6. Kasai T, Narui K, Dohi T, et al. Prognosis of patients with heart failure and obstructive sleep apnea treated with continuous positive airway pressure. Chest 2008;133:690-696
7. Smith LA, Vennelle M, Gardner RS, et al. Auto-titrating continuous positive airway pressure therapy in patients with chronic heart failure and obstructive sleep apnoea: a randomized placebo-controlled trial. Eur Heart J 2007;28:1221-1227 (Pubitemid 47343854)
8. Wang H, Parker JD, Newton GE, et al. Influence of obstructive steep apnea on mortality in patients with heart failure. J Am Coll Cardiol 2007;49:1625-1631 (Pubitemid 46551635)
9. Arzt M, Floras JS, Logan AG, et al. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation 2007;115:3173-3180 (Pubitemid 47012231)
10. Bradley TD, Logan AG, Kimoff RJ, et al. Continuous positive airway pressure for central sleep apnea and heart failure. N Engl J Med 2005;353:2025-2033 (Pubitemid 41609095)
11. Kiely JL, Deegan P, Buckley A, et al. Efficacy of nasal continuous positive airway pressure therapy in chronic heart failure: importance of underlying cardiac rhythm. Thorax 1998;53:957-962 (Pubitemid 28494336)
12. Kanagala R, Murali NS, Friedman PA, et al. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation 2003;107:2589-2594 (Pubitemid 36628941)
13. Garni AS, Hodge DO, Herges RM, et al. Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. J Am Coll Cardiol 2007;49:565-571 (Pubitemid 46177437)
14. Bradley TD, Floras JS. Obstructive sleep apnoea and its cardiovascular consequences. Lancet 2009;373:82-93.
15. Romero-Corral A, Somers VK, Pellikka PA, et al. Decreased right and left ventricular myocardial performance in obstructive sleep apnea. Chest 2007;132:1863-1870
16. Shivalkar B, Van de Heyning C, Kerremans M, et al. Obstructive sleep apnea syndrome: more insights on structural and functional cardiac alterations, and the effects of treatment with continuous positive airway pressure. J Am Coll Cardiol 2006;47:1433-1439
17. Eckert DJ, Jordan AS, Merchia P, et al. Central sleep apnea: Pathophysiology and treatment. Chest 2007;131:595-607. (Pubitemid 46280426)
18. Sin DD, Logan AG, Fitzgerald FS, et al. Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne-Stokes respiration. Circulation 2000;102:61-66 (Pubitemid 30430554)
19. Philippe C, Stoica-Herman M, Drouot X, et al. Compliance with and effectiveness of adaptive servoventilation versus continuous positive airway pressure in the treatment of Cheyne-Stokes respiration in heart failure over a six month period. Heart 2006;92:337-342 (Pubitemid 43295100)
20. Morgenthaler TI, Gay PC, Gordon N, et al. Adaptive servoventilation versus noninvasive positive pressure ventilation for central, mixed, and complex sleep apnea syndromes. Sleep 2007;30:468-475 (Pubitemid 46668704)
21. Teschler H, Dohring J, Wang YM, et al. Adaptive pressure support servo-ventilation: a novel treatment for Cheyne-Stokes respiration in heart failure. Am J Respir Crit Care Med 2001;164:614-619 (Pubitemid 32801665)
22. Kasai T, Narui K, Dohi T, et al. Efficacy of nasal bi-level positive airway pressure in congestive heart failure patients with cheyne-stokes respiration and central sleep apnea. Circ J 2005;69:913-921 (Pubitemid 41124258)
23. Kohnlein T, Welte T, Tan LB, et al. Assisted ventilation for heart failure patients with Cheyne-Stokes respiration. Eur Respir J 2002;20:934-941 (Pubitemid 35175131)
24. Allam JS, Olson EJ, Gay PC, et al. Efficacy of adaptive servoventilation in treatment of complex and central steep apnea syndromes. Chest 2007;132:1839-1846
25. Kasai T, Narui K, Dohi T, et al. First experience of using new adaptive servo-ventilation device for Cheyne-Stokes respiration with central sleep apnea among Japanese patients with congestive heart failure: report of four clinical cases. Circ J 2006;70:1148-1154 (Pubitemid 44386995)
26. Peppered JC, Masked NA, Jones DR, et al. A randomized controlled trial of adaptive ventilation for Cheyne-Stokes breathing in heart failure. Am J Respir Crit Care Med 2003;168:1109-1114 (Pubitemid 37338941)
27. Walsh JT, Andrews R, Starling R, et al. Effects of captopril and oxygen on sleep apnoea in patients with mild to moderate congestive cardiac failure. Br Heart J 1995;73:237-241
28. Tamura A, Kawano Y, Naono S, et al. Relationship between betablocker treatment and the severity of central sleep apnea in chronic heart failure. Chest 2007;131:130-135 (Pubitemid 46122984)
29. Tamura A, Kawano Y, Kadota J. Carvedilol reduces the severity of central sleep apnea in chronic heart failure. Circ J 2009;73:295-298
30. Arzt M, Schutz M, Wensel R, et al. Nocturnal continuous positive airway pressure improves ventilatory efficiency during exercise in patients with chronic heart failure. Chest 2005;127:794-802. (Pubitemid 40775507)
31. Sasayama S, Izumi T, Seino Y, et al. Effects of nocturnal oxygen therapy on outcome measures in patients with chronic heart failure and cheyne-stokes respiration. Circ J 2006;70:1-7. (Pubitemid 43021226)
32. Sasayama S, Izumi T, Matsuzaki M, et al. Improvement of quality of life with nocturnal oxygen therapy in heart failure patients with central sleep apnea. Circ J 2009;73:1255-1262
33. Xie A, Skatrud JB, Puleo DS, et al. Exposure to hypoxia produces long-lasting sympathetic activation in humans. J Appl Physiol 2001;91:1555-1562 (Pubitemid 32900346)
34. Jelic S, Padeletti M, Kawut SM, et al. Inflammation, oxidative stress, and repair capacity of the vascular endothelium in obstructive steep apnea. Circulation 2008;117:2270-2278
35. Andreas S, Plock EH, Heindl S, et al. Nasal oxygen effects on arterial carbon dioxide pressure and heart rate in chronic heart failure. Am J Cardiol 1999;83:795-8. A10. (Pubitemid 29116373)
36. Garrigue S, Bordier P, Jais P, et al. Benefit of atrial pacing in sleep apnea syndrome. N Engl J Med 2002;346:404-412 (Pubitemid 34437695)
37. Simantirakis EN, Schiza SE, Chrysostomakis SI, et al. Atrial overdrive pacing for the obstructive sleep apnea-hypopnea syndrome. N Engl J Med 2005;353:2568-2577 (Pubitemid 41785894)
38. Krahn AD, Yee R, Erickson MK, et al. Physiologic pacing in patients with obstructive sleep apnea: a prospective, randomized crossover trial. J Am Coll Cardiol 2006;47:379-383 (Pubitemid 43063258)
39. Melzer C, Fietze I, Duru F, et al. Nocturnal overdrive pacing for the treatment of sleep apnea syndrome. Sleep 2006;29:1197-1202 (Pubitemid 44484813)
40. Sharafkhaneh A, Sharafkhaneh H, Bredikus A, et al. Effect of atrial overdrive pacing on obstructive sleep apnea in patients with systolic heart failure. Sleep Med 2007;8:31-36 (Pubitemid 46044131)
41. Sinha AM, Bauer A, Skobel EC, et al. Long-term effects of dynamic atrial overdrive pacing on sleep-related breathing disorders in pacemaker or cardioverter defibrillator recipients. Pacing Clin Electrophysiol 2009;32(Suppl. 1):S219-22.
42. Gabor JY, Newman DA, Barnard-Roberts V, et al. Improvement in Cheyne-Stokes respiration following cardiac resynchronisation therapy. Eur Respir J 2005;26:95-100. (Pubitemid 40945936)
43. Luthje L, Renner B, Kessels R, et al. Cardiac resynchronization therapy and atrial overdrive pacing for the treatment of central sleep apnoea. Eur J Heart Fail 2009;11:273-280
44. Oldenburg O, Faber L, Vogt J, et al. Influence of cardiac resynchronisation therapy on different types of sleep disordered breathing. Eur J Heart Fail 2007;9:820-826 (Pubitemid 47212825)
45. Sinha AM, Skobel EC, Breithardt OA, et al. Cardiac resynchronization therapy improves central sleep apnea and Cheyne-Stokes respiration in patients with chronic heart failure. J Am Coll Cardiol 2004;44:68-71.
46. Skobel EC, Sinha AM, Norra C, et al. Effect of cardiac resynchronization therapy on sleep quality, quality of life, and symptomatic depression in patients with chronic heart failure and Cheyne-Stokes respiration. Sleep Breath 2005;9:159-166 (Pubitemid 44184312)
47. Yiu KH, Lee KL, Lau CP, et al. Alleviation of pulmonary hypertension by cardiac resynchronization therapy is associated with improvement in central sleep apnea. Pacing Clin Electrophysiol 2008;31:1522-1527
48. Stanchina ML, Ellison K, Malhotra A, et al. The impact of cardiac resynchronization therapy on obstructive sleep apnea in heart failure patients: a pilot study. Chest 2007;132:433-439 (Pubitemid 47282373)
49. Kara T, Novak M, Nykodym J, et al. Short-term effects of cardiac resynchronization therapy on sleep-disordered breathing in patients with systolic heart failure. Chest 2008;134:87-93. (Pubitemid 352008768)
50. Sredniawa B, Lenarczyk R, Kowalski O, et al. Sleep apnoea as a predictor of mid- and long-term outcome in patients undergoing cardiac resynchronization therapy. Europace 2009;11:106-114
51. Javaheri S, Parker TJ, Wexler L, et al. Effect of theophylline on sleep-disordered breathing in heart failure. N Engl J Med 1996;335:562-567 (Pubitemid 26272311)
52. Javaheri S. Acetazolamide improves central sleep apnea in heart failure: a double-blind, prospective study. Am J Respir Crit Care Med 2006;173:234-237 (Pubitemid 43187897)
53. Lorenzi-Filho G, Rankin F, Bies I, et al. Effects of inhaled carbon dioxide and oxygen on cheyne-stokes respiration in patients with heart failure. Am J Respir Crit Care Med 1999;159:1490-1498 (Pubitemid 29227859)